Basic Information
Basic information for HCG18-239-60aa
Peptide Name HCG18-239-60aa
Genome Position chr6:30293532-30293711[-]
Species Human
Peptide Sequence MKDLAWEEVVRTLGEKKEGKNSFTHAEVNLNLHLEKQKKKTHTFPFCASLPRVLAKGLAK
Peptide Length 60
Unique No (HCG18-233-60aa,HCG18-235-60aa,HCG18-237-60aa,HCG18-238-60aa,HCG18-240-60aa,HCG18-241-60aa,HCG18-247-60aa,HCG18-248-60aa,HCG18-249-60aa,HCG18-250-60aa,HCG18-251-60aa,HCG18-254-60aa,HCG18-255-60aa,HCG18-256-60aa,HCG18-257-60aa,HCG18-260-60aa,HCG18-261-60aa,HCG18-263-60aa,HCG18-265-60aa)
Grand Average of Hydropathicity -0.6133
Relative Molecular Mass 7910.03
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000231074;HCG18
Transcript ID/Name ENST00000454129;HCG18-239
Transcript Length 4433
Coding Ability 0.423
DNA Sequence Corresponding to Peptide ATGAAGGATTTAGCCTGGGAGGAGGTGGTGAGAACTCTGGGAGAGAAAAAAGAAGGAAAGAATAGTTTTACCCATGCTGAAGTTAATTTAAACCTTCACCTAGAGAAGCAAAAAAAAAAAACCCACACTTTCCCATTTTGTGCCTCCCTTCCTAGAGTTTTAGCCAAAGGTTTAGCTAAG
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :